Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2025-12-29 @ 2:20 AM
Study NCT ID:
NCT04098692
Status:
COMPLETED
Last Update Posted:
2021-01-19
First Post:
2019-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects
Sponsor:
Basilea Pharmaceutica
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DZB-CS-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None